MDSCs and T cells in solid tumors and non-Hodgkin lymphomas: an immunosuppressive speech
Chiara Cioccarelli, Barbara Molon
Abstract
Myeloid-derived suppressor cells (MDSCs) are a heterogeneous subset of cells expanded during multiple pathological settings, including cancers. In tumors, MDSCs are dominant drivers of T-cell immunosuppression. To accomplish their job, they exploit multiple mechanisms ultimately leading to the paralysis of anti-tumor immunity. Among the variety of MDSC-ways of working within the tumor microenvironment, the generation of reactive species and the metabolic reprogramming have emerged as pivotal determinants of their immunosuppressive power. In this review we will overview integral mechanisms of MDSC-mediated immunosuppression in solid tumors, with a particular focus on Non-Hodgkin lymphoma.
Topics & Concepts
ImmunosuppressionLymphomaMyeloid-derived Suppressor CellImmunologyReprogrammingTumor microenvironmentPathologicalMedicineT cellSuppressorImmune systemBiologyCancer researchPathologyCellCancerInternal medicineGeneticsImmune cells in cancerImmune Cell Function and InteractionHistone Deacetylase Inhibitors Research